Imaging instrumentation for ultrasound contrast agents

The past decade has seen dramatic improvements in ultrasound imaging system performance. The introduction of color Doppler imaging has added a new dimension to blood flow measurement, displaying blood flow as a real-time map over a two-dimensional image rather than as a spectrum from the single point of pulsed Doppler or the single line of continuous wave Doppler. The more recent refinement of power Doppler (also known as Color Power AngiographyTM) has increased the imaging sensitivity of color Doppler to the point where images such as that shown in Figure 1 have become common place. If the function of a contrast agent is to enhance the echo from blood, is such help needed with state of the art ultrasound instruments? We believe that it is. First, not all patients yield images like that shown in Figure 1, nor can such images be obtained in all anatomical locations. Contrast agents can extend the anatomical scope, and hence the clinical utility, of conventional ultrasound imaging. Second, as we shall see, contrast agents allow renegotiation of some of the fundamental compromises inherent in a blood flow image and allow system design changes which result in improvements that go far beyond Doppler signal enhancement.

[1]  David S. Martin,et al.  MRI in Pediatric Neuroradiology , 1992 .

[2]  F. Dunn,et al.  Ultrasonic Scattering in Biological Tissues , 1992 .

[3]  K J Parker,et al.  Contrast agents in diagnostic ultrasound. , 1989, Ultrasound in medicine & biology.

[4]  Wesley L. Nyborg,et al.  Non-linear behaviour and stability of trapped micron-sized cylindrical gas bubbles in an ultrasonic field , 1983 .

[5]  Navin C. Nanda,et al.  Advances in Echo Imaging Using Contrast Enhancement , 1997, Springer Netherlands.

[6]  Peter N. Burns,et al.  Harmonic power mode Doppler using microbubble contrast agents: an improved method for small vessel flow imaging , 1994, 1994 Proceedings of IEEE Ultrasonics Symposium.

[7]  Sanjiv Kaul,et al.  Quantification of Myocardial Perfusion With Myocardial Contrast Echocardiography During Left Atrial Injection of Contrast: Implications for Venous Injection , 1994, Circulation.

[8]  Barry B. Goldberg,et al.  Intravenous Contrast Agent For Ultrasound Doppler: In Vivo Measurement Of Small Tumor Vessel Dose-response , 1990, [1990] Proceedings of the Twelfth Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[9]  K. Shung,et al.  On the application of ultrasonic contrast agents for blood flowmetry and assessment of cardiac perfusion. , 1990, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[10]  D O Cosgrove,et al.  Breast carcinoma: measurement of tumor response to primary medical therapy with color Doppler flow imaging. , 1994, Radiology.

[11]  F Forsberg,et al.  Galactose‐based intravenous sonographic contrast agent: experimental studies , 1993, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[12]  T. A. Maniatis,et al.  Two-dimensional velocity reconstruction strategies for color flow Doppler ultrasound images. , 1994, Ultrasound in medicine & biology.

[13]  Peter N. Burns,et al.  Clinical applications of Doppler ultrasound , 1988 .

[14]  B B Goldberg,et al.  Hepatic tumors: signal enhancement at Doppler US after intravenous injection of a contrast agent. , 1990, Radiology.

[15]  T. Porter,et al.  Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles. Demonstration and potential mechanisms. , 1995, Circulation.

[16]  S. Savader,et al.  US-guided pseudoaneurysm repair with a compression device. , 1993, Radiology.